Determination of Adequate TUberculosis Regimen in Adults and adolescents hospitalised with HIV-associated severe immune suppression – NCT04738812
Finally meeting! The kick-off meeting has been blended – both teleconferencing and face-to-face, the latter especially for European participants. Around 13 people gathered in Montpellier, and over 20 participated via ZOOM. Agenda: Day 1 Day 2 There will be two Continue reading DATURA Kick-Off Meeting: 14-15 Sept. 2020
Day 2 15.9.20 1:45 – 2:00 pm (European time) Zoom teleconference opening 2:00 – 2:20 pm 9- Synthesis of day 1: PSC Chair (15 mn) Discussion (5 mn) 2:20 – 3:40 pm 10- Pharmacology of anti-TB drugs & ART (40 Continue reading Kick off meeting 15.9.20 (Day 2)
1st meeting of the DATURA Project Steering Committee Day 1 14.9.20 1:45 – 2:00 pm (European time) Zoom teleconference opening 2:00 – 2:30 pm 1- Welcome session: F.Xavier Blanc & Didier Laureillard (10 mn) Introduction of each participant (20 mn) Continue reading Kick off meeting 14.9.20 (Day 1)
Several Datura researchers were part of a team that has just published a paper in the New England Journal of Medicine (NEJM). The Datura researchers included François-Xavier Blanc (first author) Maryline Bonnet, Conrad Muzoora, Laurence Borand, Delphine Rapoud and Didier Continue reading Unravelling challenges in the “cursed duet” of HIV and TB
THE POTENTIAL IMPACT OF THE COVID-19 RESPONSE ON TUBERCULOSIS IN HIGH-BURDEN COUNTRIES: A MODELLING ANALYSIS Report released 1 May, 2020 The Report was developed by Stop TB Partnership in collaboration with Imperial College, Avenir Health, Johns Hopkins University and USAID. Continue reading COVID-19 and TB
The European and Developing Countries Clinical Trials Partnership (EDCTP) signed the Grant 14 April 2020. The Agreement enters into force from this date. However, the official starting date of the project period is 1 May 2020. The project will last Continue reading DATURA has officially begun!